OverT Bio
New York
About OverT Bio
OverT Bio operates as a biotech company that provide cell therapy for cancers.. The company's cell therapies identify and develop novel genetic modifications that will help immune cells overcome barriers created by tumors and lead to effective and durable immunotherapies, helping the healthcare industry to identify and cure cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $16.1M
- Funding stage: Seed
- Last round: Grant (Nov 2024)
- Website: overt.bio
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/overt-bio-62188 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.